相关实验视频

Updated: Jun 29, 2025

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

在分子生物标志物和生物材料基础免疫疗法的创新,用于头部和部癌症

Sarah Anne Wong¹, Victoria A Manon², Simon Young²

¹School of Medicine, Orthopaedic Trauma Institute, University of California San Francisco, 2550 23rd St., Bldg. 9, 3rd Floor, San Francisco, CA 94110 USA.

Current surgery reports

|March 25, 2024

概括

口腔状细胞癌 (OSCC) 的存活率正在通过新的分子生物标志物和免疫疗法得到改善. 这些进展提供了更准确的风险评估和有针对性的治疗,减少毒性和改善头癌患者的治疗结果.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
分子诊断学分子诊断

背景情况:

口腔状细胞癌 (OSCC) 的存活率因当前诊断工具和向治疗的局限性而停滞不前.
临床病理学特征,包括瘤分期,缺乏准确的患者风险分层和辅助治疗决策的精度.
传统的OSCC疗法具有显著的毒性和有限的疗效.

研究的目的:

审查最近在头癌诊断和治疗方面的进展.
突出新型分子生物标志物和免疫疗法的潜力,以改善OSCC患者的治疗结果.
讨论局部控制释放配方在减少治疗毒性的影响.

主要方法:

对用于OSCC风险评估的分子生物标志物的当前文献的综述.
对头癌免疫疗法的最新发展进行分析.
评估用于局部癌症治疗的新型药物输送系统.

主要成果:

分子生物标志物面板能够进行非侵入性,更早,更准确的患者风险评估.
新型免疫疗法利用宿主免疫反应,可以建立免疫记忆以防止复发.
局部控制释放配方可降低治疗毒性,并允许降低其他疗法的升级.

结论:

新兴的分子生物标志物和免疫疗法代表了OSCC诊断和治疗的范式转变.
这些创新有望提高生存率,提高风险分层的精度,并减少与治疗相关的毒性.
未来的研究应该专注于将这些新的方法纳入临床实践,以更好地管理头癌症.

关键词:

生物标志物生物标志物生物材料是一种生物材料.头癌是头部和部的癌症.免疫治疗是一种免疫疗法.非侵袭性的活检活检.口腔癌是一种口腔癌.

更多相关视频

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...